NCT00754403View on ClinicalTrials.gov

Efficacy of Pioglitazone and Fortamet Combination Therapy in Subjects With Type 2 Diabetes

PHASE4CompletedINTERVENTIONAL
Enrollment

312

Participants

Timeline

Start Date

July 31, 2005

Primary Completion Date

October 31, 2006

Study Completion Date

October 31, 2006

Conditions
Diabetes Mellitus
Interventions
DRUG

Pioglitazone and metformin

Pioglitazone 30 mg, tablets, orally, once daily and metformin 1000 mg, tablets, orally once daily for up to 16 weeks.

DRUG

Metformin

Pioglitazone placebo-matching tablets, orally, once daily and metformin 1000 mg, tablets, orally once daily for up to 16 weeks.

Sponsors

Lead Sponsor

Takeda
All Listed Sponsors
lead

Takeda

INDUSTRY